Cutaneous Sarcoidosis is a rare multisystem disease that manifests as lesions on the skin. These lesions can look many ways and their disfiguring nature can have a significant psychosocial impact.

BEACON is a Phase 2 study focused on developing a drug for adults with Cutaneous Sarcoidosis. The study aims to offer hope and new possibilities to those living with this condition.

The logo I designed symbolizes a beacon of hope, reflecting the study’s mission to illuminate a path toward improved treatment and care. This logo will be featured across study-related materials and merchandise, ensuring a cohesive and inspiring representation of the BEACON Study’s objectives.